Search

everythinglearnresearchcommunity

for

Search:↓

Middle-aged patients, those in the Northeast, with comprehensive insurance, extensive hair loss, or additional health issues, and young or older females face higher alopecia areata medical costs.

Abatacept may help some people with alopecia areata regrow hair.

Unmarried individuals and those with diabetes have a poorer quality of life with alopecia areata.

Ayurvedic Shamana therapy effectively treats alopecia areata with minimal side effects.

Patients with alopecia areata in Saudi Arabia understand the condition's seriousness but still face significant psychological challenges.

Baricitinib significantly regrows hair in severe alopecia areata patients.

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Oxidative stress is linked to mild patchy alopecia areata.

Prachchhana Karma and Ayurvedic medication can help treat patchy hair loss.

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

JAK inhibitors can effectively regrow hair in alopecia areata patients, but ongoing treatment is needed to maintain results.

Baricitinib effectively promotes hair regrowth in both scalp and nonscalp areas for alopecia areata universalis patients.

Over 45% of patients with alopecia areata benefit from ritlecitinib, mostly within a year.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Alopecia areata patients often have undetected thyroid issues, so routine thyroid screening is recommended.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

Patients with alopecia areata prefer treatments that regrow scalp hair quickly over how often they need to take the medication.

Baricitinib may effectively treat oral lichen planus.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Higher air pollution increases the risk of alopecia areata.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Vibration assisted analgesia reduces pain during corticosteroid therapy for alopecia.